Scale and scope Vivo Capital is a global healthcare investment firm with approximately $6.1 billion in regulatory assets under management and a diverse multi-fund platform spanning venture, growth, buyout, and public equities, indicating a broad potential for sophisticated financial products and advisory services aligned to large, multi-asset mandates.

Healthcare focus The firm invests across biotechnology, pharmaceuticals, medical devices, and healthcare services targeting the largest healthcare markets, presenting opportunities for specialized solutions in fund strategies, portfolio analytics, and deal-flow partnerships within the life sciences sector.

Global footprint Headquartered in Palo Alto with offices in Asia, Vivo Capital’s expansive geographic reach suggests readiness for cross-border collaboration, regional fundraising support, and localized market intel services to help accelerate international investments.

Tech stack readiness AdRoll, Oracle Cloud, Azure Active Directory, Braze, Marketo, PayPal, Slack, and Bitbucket indicate a mature, cloud-enabled operation with potential needs for advanced data management, security, CRM automation, and integration services to optimize deal sourcing and portfolio monitoring.

Market positioning With Revenue between $1B-$10B and a competitive landscape featuring firms like Domain Associates and Canaan, Vivo can be approached with tailored value propositions around fund-level performance analytics, LP communications, and co-investment opportunities to enhance competitiveness.